NCT04713488: An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine |
|
|
| Active, not recruiting | 1/2 | 110 | RoW | Sputnik Light, vector vaccine to help prevent the SARS-CoV-2-induced coronavirus infection | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, RDIF (Russian Direct Investment Fund) | COVID-19 Prevention | 07/21 | 07/21 | | |
